NIVF eps in a glimpse
Analyst Rating Consensus
0
Ratings
NIVF Price Target
Highest Price Target
N/A
0% Upside
)Mean Price Target
N/A
0% Upside
)Lowest Price Target
N/A
0% Upside
)NIVF Recent Analyst Ratings
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
Frequently Asked Questions
Brokerage firms have given NIVF stock an average recommendation of N/A. 0 analysts have given their ratings to NIVF out of which 0 analysts have given strong buy call, 0 analysts have given buy call, 0 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of - gives the stock implied downside of roughly 0% over the next year or so.
Analysts suggest NIVF's stock price would rise to a high of -.
Within the next 12 months, analysts predict the NIVF stock price could move to -.
NIVF stock has an average analyst estimate of -.
NIVF shares are currently trading 0% below this price target.
Its quarterly earnings per share (EPS) came in at - versus consensus estimates of -, and null the comparable year-ago quarter’s EPS of -.
NIVF's forecasts by analysts estimating quarterly EPS at - and - for the whole year.
The analysts have projected N/A EPS growth for NIVF in the next five years, compared to growth rates of N/A in the past five years.